Proposed revision to NSF/ANSI 455-4 – Good Manufacturing Practices for Over-the-Counter Drugs (455-4i17r1) The proposed revision will add more clarity on what is required for traceability and mock recalls.
06322: Approval of 455-4i17r1 - Mock Recall
Document (Archive)
2020-03-18
BLANK Comment Template.docx
Document
2020-02-21
Issue 6 Mock Recall Criteria (gmpDS-2019-5) Straw Ballot Comments.docx
2020-02-06
gmpOTC-2019-5_4.7.15 (455-4i17r1).docx
About UsParticipateTerms of UsePrivacy Policy